secwatch / observer
8-K filed December 1, 2023, 6:59 PM ET ticker XCUR CIK 0001698530
other material confidence high sentiment negative materiality 0.75

EXICURE, INC. (XCUR): auditor change — Exicure restates Q1, Q2 2023; reclassifies ~$1.5M R&D expenses to G&A

EXICURE, INC.

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

EXICURE, INC. reported that prior financial statements should not be relied upon.

Action
non reliance
Exact text from the filing
Therefore, the financial statements for the Affected Periods should no longer be relied upon and are to be restated. Approximately $0.6 million of expenses in the first quarter of 2023 will be corrected from research and development into general and administrative. These expenses related to separation pay from former R&D employees and legal costs associated with our intellectual property. Approximately $0.9 million of expenses in the second quarter of 2023 will be corrected from research and development into general and administrative. These expenses primarily related to the office lease, depreciation of scientific equipment, legal costs associated with our intellectual property, and other wind down costs. The corrections do not impact our net loss for the periods. The Company expects to file restated financial statements for the Affected Periods on two separate Form 10-Q/A's as soon as
View on SEC.gov

6 auditor changes filed in the last 30 days. Browse all auditor changes →

EXICURE, INC. filing history →

Source: SEC EDGAR
accession 0001698530-23-000123
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.